Clinical and radiobiological consideration of cyclical hypofractionated radiation therapy also known as QUAD Shot for neglected skin cancer disfiguring the face of a non-compliant patient who was refusing surgery and protracted radiation therapy: case report
Radiation Oncology Journal. 2019;37(2):143-148 
Radiobiological rationale and clinical implications of hypofractionated radiation therapy
Cancer/Radiothérapie. 2011;15(3):221-229
Cyclical hypofractionated radiotherapy also known as “QUAD Shot” alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities
Head & Neck. 2017;39(4):E55-E60
Hypofractionated Palliative Radiation Therapy With Concurrent Chemotherapy for Advanced Head-and-Neck Cancer: The QUAD-Shot Regimen
International Journal of Radiation Oncology*Biology*Physics. 2014;88(2):508
Hypofractionated radiation therapy in non-small cell lung cancer (NSCLC)
Lung Cancer. 1994;11:131
Patient Selection for Hypofractionated Whole Breast Radiation Therapy for Treatment of Early-Stage Breast Cancer
Short Course Breast Radiotherapy. 2016;121-135
Stereotactic Body Radiation Therapy Gains Radiobiological Advantages Not in Non-Small Cell Lung Cancer Cells After Radiation But in Early Passage Cells Compared to Conventional Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics. 2016;96(2):E581
Skin (Melanoma and Nonmelanoma Skin Cancers)
Hypofractionated and Stereotactic Radiation Therapy. 2018;189-203
Hypofractionated Stereotactic Radiation Therapy for Advanced Non-Small Cell Lung Cancer: Report on Clinical Outcome and Toxicity
International Journal of Radiation Oncology*Biology*Physics. 2016;96(2):E461
Breast Cancer
Hypofractionated and Stereotactic Radiation Therapy. 2018;237-262